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TO THE EDITOR
We read with great interest the Com-
mentary by Schatton and Frank (2010)
that appeared in the July issue of
Journal of Investigative Dermatology.
They highlight one of the major findings
of our article, published in the same
issue of the Journal (Perego et al.,
2010): that malignant melanoma-initi-
ating cells (MMIC) can also be found in
melanoma cell lines when grown as
adherent cells. We found that melano-
spheres could be derived from both
melanoma single-cell suspensions ob-
tained from fresh tumor specimens,
and from melanoma cells previously
adapted to grow as adherent cells.
However, it should be noted that we
found the frequency of self-renewing
cells was relatively low in adherent
cells when compared with cells from
melanospheres.
These in vitro quantitative differ-
ences were also reflected in the results
from the in vivo tumorigenic assays
using immunocompromised mice,
clearly suggesting a greater enrichment
of tumorigenic cells in melanospheres
compared with adherent cells. More-
over the latency of xenografts generated
in primary recipients by melanosphere
cells was much shorter than that ob-
served with adherent melanoma cells.
Likewise, when xenografts were serially
transplanted into secondary and tertiary
hosts, the difference in successful tumor
grafting between the two groups be-
came even more apparent. Thus, for
these reasons we believe the differences
must reflect a biological difference in
the two populations, although in our
study the lack of a true limiting dilution
analysis in vivo precluded any numer-
ical quantification of MMIC in melano-
spheres and adherent melanoma cells,
hence we cannot assess to what extent
melanospheres are enriched in MMIC
as compared with adherent melanoma
cells.
On the other hand, it is accepted
that spheres are not composed entirely
of stem cells, as highlighted by two
recent articles exploring heterogeneity
in mammospheres and melanospheres
(Pece et al., 2010; Roesch et al., 2010).
Although we agree with Schatton and
Frank, who advise caution in consider-
ing sphere formation as the definitive
methodology for identifying cancer
stem cells, these latest papers never-
theless stress the utility of sphere
cultures to investigate cancer stem cell
biology, including the fact that cancer
stem cells may be more dynamically
regulated than hitherto suspected
(Heddleston et al, 2009; Vermeulen
et al., 2010)—and thus not strictly adher-
ing to a hierarchical system. The con-
siderable phenotypic heterogeneity that
we found in our melanospheres can be
ascribed to the relatively poor enrichment
in melanoma stem cells, a view favored
by Schatton and Frank, though equally
well heterogeneity may be a reflection of
MMIC diversity that increases with genetic
instability as tumors progress (Piccirillo
et al, 2009; Greaves 2010).
Regarding the prospective isolation
of cancer stem cells from melanoma, a
confusing array of markers have
been proposed, ranging from none at
all (Quintana et al., 2008) to CD133
(Monzani et al., 2007), ABCB5
(Schatton et al., 2008), CD271 (Boiko
et al., 2010), and JARID1B (Roesch
et al., 2010). The emergence of geneti-
cally distinct clones with metastatic
melanoma-initiating capacity may be
behind this plethora of markers.
On the other hand, using the same
methods (FACS isolation and sphere
formation) has lead to the identification
of a population of tumor-initiating cells
expressing CD133 across a surprising
range of tumor types, including colo-
rectal cancer, Ewing’s sarcoma, and
hepatocellular carcinoma (O’Brien
et al., 2009). Thus, although these
analytical approaches have limitations
(Jensen and Parmar, 2006; Rosen and
Jordan, 2009; Alexander et al., 2009),
they do seem useful for identifying
tumor-initiating cells that are the same
as cancer stem cells. Of note, one of
our melanospheres, Me15888S, was
highly enriched in cells expressing two
cell-surface markers found to be asso-
ciated with MMIC, namely CD133 and
CD271 (Monzani et al., 2007; Boiko
et al., 2010).
In conclusion, the field of cancer
stem cells, especially in solid tumors, is
still in its infancy. Several methodo-
logical issues still remain, most notably
a careful assessment of the validity and
limitations of the various analytical
approaches. However, as highlighted
by the authors of the Commentary, the
‘must’ that should always be kept in
mind when evaluating any new data is
indeed its relevance for patients and
clinical transferability.
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